# Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-medicaid-coverage-weight-loss-drugs.html) · 2026-11-16 · Medicine
Page: https://themorning.science/story/ending-medicaid-coverage-for-weight-loss-drugs-linked-to-sharp-drop-in-glp-1-use-e3de48525d452c33
Kind: research · Impact: medium

## In brief

- Medicaid prescriptions for GLP-1 medications approved for weight loss fell sharply after four states ended coverage of the drugs.
- A new study led by researchers at the University of Pittsburgh reports the findings, published in JAMA.
- The study says state coverage decisions can noticeably change how many people use these medications.

## Why it matters

It shows that state Medicaid coverage rules can measurably change access to GLP-1 weight-loss drugs, which matters for anyone assessing health policy or patient access.

## Coverage

- [Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use](https://medicalxpress.com/news/2026-11-medicaid-coverage-weight-loss-drugs.html) — Medical Xpress - latest medical and health news stories, 2026-11-16

Tags: glp-1, medicaid, obesity, health policy, drug coverage

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
